Artificial Organ Market By Manufacturers, By Type (Artificial Heart, Artificial Eye, Artificial Pancreas, Artificial Ear, Artificial Urinary Bladder), By Method of Fixation (Implantable Technology, Wearable Technology), By Technology (Electronic, Mechanical), and By Regions (North America, Europe, Middle East and Africa, Latin America and Asia Pacific) - Global Outlook to 2026
Report ID: 391278 | Feb 2020 | No. of Pages: 120
|
Covid-19 Impact Analysis & Forecast
Global Artificial Organ Market is valued USD 31.91 Billion in 2019 and is projected is to exhibit 8.7 % CAGR during the forecast period. The market is projected to be around USD 57.22 Billion by 2026. The market is driven by the developing technological advancements in the artificial organ sector.
The artificial organ is a pathological organ or tissue that is fixed into human interfacing with living tissue to replace an original organ, to duplicate or augment a particular function so the patient may reverse to normal life as soon as possible. Sometimes the replaced function does not have to be related to life support.
Artificial Organ Market Dynamics
The factors that affect the growth of the market are such as the rapidly aging global population, developing technological advancements in the artificial organ sector, raising the number of people suffering from organ failures, and growing incidents of motor accidents and other work-related accidents. Furthermore, demand for artificial organs is likely to grow significantly due to the rise in lifestyle diseases that lead to the need for organ transplantation in particular for heart and kidney.
However, the high of the artificial organs including engineered devices, and tissues are likely to restrain the growth of artificial organs. At the same time, researchers are focusing on developing new artificial organs with better materials, and advanced process to reduce the manufacturing cost.
Artificial Organ Market Insight
Based on the region, North America is expected to dominate the market of an artificial organ, due to the U.S. is expected to grab a major market share in the global market of artificial organs on account of the high demand for artificial organs in that region. The growing rate of injuries and organ failures is expected to drive the market growth. Additionally, the rise in expenditure of the health sector, and growing income levels are also contributing to the growth of the market. Furthermore, the markets of Europe and Asia-pacific are expected to grow at a significant rate during the forecast period due to the higher consumer base, and increasing healthcare initiatives taken by the government.
Artificial Organ Market Segmentation
The global Artificial Organ Market is segmented into type, method of fixation, technology, and region. On the basis of the type the market is divided into artificial heart, artificial eye, artificial pancreas, artificial ear, and artificial urinary bladder. Based on method of fixation the market is segmented into implantable technology, wearable technology. Based on technology the market is further divided into electronic, mechanical. And based on the geography the market is further segregated into North America, Latin America, Europe and Asia Pacific.
Artificial Organ Market Competitive Landscape
The key players in Artificial Organ Market are listed as Advanced Bionics AG and affiliates, Boston Scientific Corporation, CARMAT, Cochlear Ltd., Dexcom, Inc., Insulet Corporation, KeraMed, Inc., MED-EL, Medtronic plc, Oticon Medical, PIXIUM VISION, Retina Implant AG, Second Sight Medical Products, Inc., SynCardia Systems, LLC, Tandem Diabetes Care, Inc., and Other.
The artificial organ is a pathological organ or tissue that is fixed into human interfacing with living tissue to replace an original organ, to duplicate or augment a particular function so the patient may reverse to normal life as soon as possible. Sometimes the replaced function does not have to be related to life support.
Artificial Organ Market Dynamics
The factors that affect the growth of the market are such as the rapidly aging global population, developing technological advancements in the artificial organ sector, raising the number of people suffering from organ failures, and growing incidents of motor accidents and other work-related accidents. Furthermore, demand for artificial organs is likely to grow significantly due to the rise in lifestyle diseases that lead to the need for organ transplantation in particular for heart and kidney.
However, the high of the artificial organs including engineered devices, and tissues are likely to restrain the growth of artificial organs. At the same time, researchers are focusing on developing new artificial organs with better materials, and advanced process to reduce the manufacturing cost.
Artificial Organ Market Insight
Based on the region, North America is expected to dominate the market of an artificial organ, due to the U.S. is expected to grab a major market share in the global market of artificial organs on account of the high demand for artificial organs in that region. The growing rate of injuries and organ failures is expected to drive the market growth. Additionally, the rise in expenditure of the health sector, and growing income levels are also contributing to the growth of the market. Furthermore, the markets of Europe and Asia-pacific are expected to grow at a significant rate during the forecast period due to the higher consumer base, and increasing healthcare initiatives taken by the government.
Artificial Organ Market Segmentation
The global Artificial Organ Market is segmented into type, method of fixation, technology, and region. On the basis of the type the market is divided into artificial heart, artificial eye, artificial pancreas, artificial ear, and artificial urinary bladder. Based on method of fixation the market is segmented into implantable technology, wearable technology. Based on technology the market is further divided into electronic, mechanical. And based on the geography the market is further segregated into North America, Latin America, Europe and Asia Pacific.
Artificial Organ Market Competitive Landscape
The key players in Artificial Organ Market are listed as Advanced Bionics AG and affiliates, Boston Scientific Corporation, CARMAT, Cochlear Ltd., Dexcom, Inc., Insulet Corporation, KeraMed, Inc., MED-EL, Medtronic plc, Oticon Medical, PIXIUM VISION, Retina Implant AG, Second Sight Medical Products, Inc., SynCardia Systems, LLC, Tandem Diabetes Care, Inc., and Other.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. DefinitionChapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & LimitationsChapter 3. Executive SummaryChapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain AnalysisChapter 5. Artificial Organ Market, By Type
5.1. Artificial Organ Market, By Type, 2018-2026
5.2. Artificial Heart
5.3. Artificial Eye
5.4. Artificial Pancreas
5.5. Artificial Ear
5.6. Artificial Urinary BladderChapter 6. Artificial Organ Market, By Method of Fixation
6.1. Artificial Organ Market, by Method of Fixation, 2018-2026
6.2. Implantable Technology
6.3. Wearable TechnologyChapter 7. Artificial Organ Market, By Technology
7.1. Artificial Organ Market, by Technology, 2018-2026
7.2. Electronic
7.3. MechanicalChapter 8. Artificial Organ Market, By Region
8.1. Artificial Organ Market, by Region, 2018-2026
8.1.1. North America
8.1.1.1. U.S
8.1.1.2. Rest of North America
8.1.2. Europe
8.1.2.1. U.K.
8.1.2.2. Germany
8.1.2.3. France
8.1.2.4. Rest of the Europe
8.1.3. Middle East & Africa (MEA)
8.1.3.1. GCC
8.1.3.2. North Africa
8.1.3.3. South Africa
8.1.3.4. Rest of MEA
8.1.4. Latin America (LATAM)
8.1.4.1. Brazil
8.1.4.2. Rest of LATAM
8.1.5. Asia Pacific (APAC)
8.1.5.1. India
8.1.5.2. China
8.1.5.3. Japan
8.1.5.4. Rest of the APACChapter 10. Competitive Landscape
10.1.1. Key Strategies Adopted by Players
10.1.2. Market Share/Positioning AnalysisChapter 10. Company Profiles10.1. Advanced Bionics AG and affiliates
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives10.2. Boston Scientific Corporation
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives10.3. CARMAT
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives10.4. Cochlear Ltd.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives10.5 Dexcom, Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives10.6. Insulet Corporation
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives10.7. KeraMed, Inc.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives10.8. MED-EL
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives10.9. Medtronic plc
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives10.10. Oticon Medical
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives10.11. PIXIUM VISION
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives10.12. Retina Implant AG
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives
10.13. Second Sight Medical Products, Inc.
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent Initiatives10.14. SynCardia Systems, LLC
10.14.1. Company Overview
10.14.2. Product Offerings
10.14.3. Financial Performance
10.14.4. Recent Initiatives10.15. Tandem Diabetes Care, Inc.
10.15.1. Company Overview
10.15.2. Product Offerings
10.15.3. Financial Performance
10.15.4. Recent Initiatives10.16. List of other companies
10.16.1. Company Overview
10.16.2. Product Offerings
10.16.3. Financial Performance
10.16.4. Recent InitiativesChapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms
1.1. Research Objective
1.2. Scope of the Study
1.3. DefinitionChapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & LimitationsChapter 3. Executive SummaryChapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain AnalysisChapter 5. Artificial Organ Market, By Type
5.1. Artificial Organ Market, By Type, 2018-2026
5.2. Artificial Heart
5.3. Artificial Eye
5.4. Artificial Pancreas
5.5. Artificial Ear
5.6. Artificial Urinary BladderChapter 6. Artificial Organ Market, By Method of Fixation
6.1. Artificial Organ Market, by Method of Fixation, 2018-2026
6.2. Implantable Technology
6.3. Wearable TechnologyChapter 7. Artificial Organ Market, By Technology
7.1. Artificial Organ Market, by Technology, 2018-2026
7.2. Electronic
7.3. MechanicalChapter 8. Artificial Organ Market, By Region
8.1. Artificial Organ Market, by Region, 2018-2026
8.1.1. North America
8.1.1.1. U.S
8.1.1.2. Rest of North America
8.1.2. Europe
8.1.2.1. U.K.
8.1.2.2. Germany
8.1.2.3. France
8.1.2.4. Rest of the Europe
8.1.3. Middle East & Africa (MEA)
8.1.3.1. GCC
8.1.3.2. North Africa
8.1.3.3. South Africa
8.1.3.4. Rest of MEA
8.1.4. Latin America (LATAM)
8.1.4.1. Brazil
8.1.4.2. Rest of LATAM
8.1.5. Asia Pacific (APAC)
8.1.5.1. India
8.1.5.2. China
8.1.5.3. Japan
8.1.5.4. Rest of the APACChapter 10. Competitive Landscape
10.1.1. Key Strategies Adopted by Players
10.1.2. Market Share/Positioning AnalysisChapter 10. Company Profiles10.1. Advanced Bionics AG and affiliates
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives10.2. Boston Scientific Corporation
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives10.3. CARMAT
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives10.4. Cochlear Ltd.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives10.5 Dexcom, Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives10.6. Insulet Corporation
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives10.7. KeraMed, Inc.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives10.8. MED-EL
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives10.9. Medtronic plc
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives10.10. Oticon Medical
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives10.11. PIXIUM VISION
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives10.12. Retina Implant AG
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives
10.13. Second Sight Medical Products, Inc.
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent Initiatives10.14. SynCardia Systems, LLC
10.14.1. Company Overview
10.14.2. Product Offerings
10.14.3. Financial Performance
10.14.4. Recent Initiatives10.15. Tandem Diabetes Care, Inc.
10.15.1. Company Overview
10.15.2. Product Offerings
10.15.3. Financial Performance
10.15.4. Recent Initiatives10.16. List of other companies
10.16.1. Company Overview
10.16.2. Product Offerings
10.16.3. Financial Performance
10.16.4. Recent InitiativesChapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms
Advanced Bionics AG and affiliates
Boston Scientific Corporation
CARMAT
Cochlear Ltd.
Dexcom, Inc.
Insulet Corporation
KeraMed, Inc.
MED-EL
Medtronic plc
Oticon Medical
PIXIUM VISION
Retina Implant AG
Second Sight Medical Products, Inc.
SynCardia Systems, LLC
Tandem Diabetes Care, Inc.
Other
Boston Scientific Corporation
CARMAT
Cochlear Ltd.
Dexcom, Inc.
Insulet Corporation
KeraMed, Inc.
MED-EL
Medtronic plc
Oticon Medical
PIXIUM VISION
Retina Implant AG
Second Sight Medical Products, Inc.
SynCardia Systems, LLC
Tandem Diabetes Care, Inc.
Other
1. This report provides in depth analysis for changing competitive dynamics and keeps you ahead of competitors
2. Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market
3. It provides a forward looking perspective on different factors driving or restraining market growth
4. It provides an eight-year forecast assessed on the basis of how the market is expected to grow
5. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of various market segment
6. Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Connect With Us
+1-707-633-0404
sales@search4research.com